1. Eli Lilly Acquires Centessa Pharmaceuticals in $6.3B Deal for Narcolepsy Drug Pipeline
Eli Lilly is making a major strategic move into sleep disorders, announcing a $6.3 billion cash acquisition of Centessa Pharmaceuticals. The deal, which values Centessa at a 38% premium over its previous closing price, is centered on securing an experimental drug pipeline designed to combat conditions like narcolepsy. ...